The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C05 | Vasoprotectives | |
| 3 | C05A | Agents for treatment of hemorrhoids and anal fissures for topical use | |
| 4 | C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use |
| Code | Title | |
|---|---|---|
| C05AX01 | Aluminium preparations | |
| C05AX02 | Bismuth preparations, combinations | |
| C05AX03 | Other preparations, combinations | |
| C05AX04 | Zinc preparations | |
| C05AX05 | Tribenoside | |
| C05AX06 |
| Active Ingredient | Description | |
|---|---|---|
| Phenylephrine |
Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion. |
|
| Ruscogenin |
|
|
| Tribenoside |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| UNIROID-HC Ointment | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| XYLOPROCT Ointment | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
